Ziana is a U.S. prescription topical gel combining clindamycin phosphate 1.2% with the retinoid tretinoin 0.025% for acne vulgaris in patients 12 years and older. The clindamycin content is equivalent to 1% clindamycin base in the finished gel. Ziana contains no benzoyl peroxide and is not simply a branded tretinoin-only cream. The ingredient-family page covers the broader two-drug combination.
The Ziana U.S. label updated in March 2026 explicitly contraindicates the product in patients with regional enteritis, ulcerative colitis or a history of antibiotic-associated colitis. It also says Ziana should not be used with erythromycin-containing products because of its clindamycin component. Tretinoin brings further counseling needs involving skin irritation and sun exposure, so copying precautions from a plain clindamycin gel is inadequate.
This brand page explains the two percentages, container identity, age range, safety restrictions and licensed-pharmacy verification. A published branded label is not proof of current stock at a particular pharmacy, and substituting a different acne combination requires professional review of both active ingredients.
The U.S. prescribing information identifies clindamycin phosphate 1.2% (equivalent to 1% clindamycin) and tretinoin 0.025% in a single aqueous-based topical gel. This product is intended for acne vulgaris at age 12 and older. It is not the same as tretinoin cream, clindamycin-only gel or clindamycin/benzoyl peroxide gel.
Product records include 30 g and 60 g tubes. Verify the drug pair, strengths, dosage form and dispensed quantity against the original prescription rather than relying on a marketplace photo. Generic combinations, if offered, require the pharmacist to check their specific product equivalence.
Tretinoin is a topical retinoid that contributes to acne treatment through a mechanism distinct from clindamycin. It also changes tolerability: redness, scaling, dryness, burning and sensitivity to sunlight can occur. The combined gel is not interchangeable with a prescription for either active ingredient alone.
The March 2026 label describes a once-daily bedtime application framework, but actual care should follow the patient-specific prescription. Avoid copying instructions from an unrelated retinoid preparation. Review all other drying or irritating skin treatments with the prescriber rather than layering them without guidance.
Ziana is a brand entity distinct from generic clindamycin/tretinoin combination products. Check both active ingredients, gel route, strengths and container quantity when reviewing a pharmacy listing.
An updated drug label supports product identification, not a claim of immediate nationwide inventory. A pharmacy may need to confirm the specific package or discuss appropriate alternative products with the prescriber.
The FDA label provides application instructions for the acne gel; patients should follow the individual prescription and not use more or more often than directed. Irritation, redness and sensitivity to sunlight may occur.
Avoid application to eyes, mouth and mucous membranes. Discuss the rest of a skincare regimen, particularly abrasive products and other potentially irritating topical medicines, with the treating clinician.
The March 2026 Ziana prescribing information explicitly contraindicates use in patients with regional enteritis, ulcerative colitis or a history of antibiotic-associated colitis. This is formal label language and must not be softened into a generic suggestion to mention bowel disease. Significant diarrhea requires prompt evaluation because topical clindamycin absorption and serious colitis have been reported.
Pregnancy or plans for pregnancy warrant a prescriber discussion because Ziana contains tretinoin; risks and available alternatives depend on the full patient context. Sun protection and irritation counseling also matter. The contraindications overview explains why these labels differ across clindamycin routes.
Ziana pairs clindamycin with tretinoin, not benzoyl peroxide. Acanya and Onexton use clindamycin with benzoyl peroxide, while CABTREO contains clindamycin, adapalene and benzoyl peroxide. Each product has a distinct label, regimen, ingredients and contraindication profile.
A patient should not infer that these are equivalent choices because they all contain clindamycin. The clindamycin/benzoyl peroxide guide clarifies the two-active alternative, while differences in prescribing require medical review.
A Ziana prescription should be matched to topical gel containing both clindamycin phosphate 1.2% and tretinoin 0.025%. A tube of tretinoin 0.025% alone omits the antibiotic, and a tube of clindamycin 1% alone omits the retinoid. Neither is the same prescribed product.
If a pharmacy offers a generic clindamycin/tretinoin gel or a different package size, the pharmacist should assess the exact product and authorization. Review prescription requirements and licensed online dispensing checks rather than assuming that an ingredient-name search proves equivalence.
The amount a patient pays for Ziana can depend on brand versus generic status, package quantity, network status, formulary preferences, deductibles and dispensing terms. No static dollar quote can represent all pharmacies or plans. Start with topical clindamycin cost factors for a route-specific checklist.
For Ziana, compare a quote on the exact clindamycin/tretinoin gel and container amount, not tretinoin-only cream or a benzoyl peroxide combination. The insurance guide addresses plan restrictions; a lower-price alternative needs its own product-level review.
The Ziana dispensing check begins with the full 1.2% clindamycin phosphate / 0.025% tretinoin gel identity. The clinician and pharmacist must distinguish it from any other clindamycin-containing acne medicine, including products that share only one ingredient or a similar percentage.
For Ziana, a tube containing only tretinoin or a gel pairing clindamycin with benzoyl peroxide is not the prescribed two-drug formula. Confirm both strengths and the topical gel presentation before dispensing.
| Check | Brand identity | What to ask the pharmacy |
|---|---|---|
| Ingredient formula | clindamycin phosphate 1.2% and tretinoin 0.025% | Does the dispensed item match the prescription? |
| Route | Topical skin use only | Is this a prescription acne gel, not oral or vaginal medication? |
| Brand/generic | Brand label; any substitutes require verification | Is the proposed alternative appropriate and permitted? |
| Pack and quantity | Manufacturer-labeled package; verify current presentation | Which package and quantity will be dispensed? |
| Cost | Plan or cash quote varies | What is the full current patient price? |
The Ziana prescribing information says it should not be used in combination with erythromycin-containing products because of the clindamycin component. Tell the prescriber about topical or systemic erythromycin products, all current acne medicines and recent courses of antibiotics. Other strong drying preparations may increase irritation.
Seek prompt clinical advice for significant persistent diarrhea, severe skin irritation or possible allergic reactions. Widespread swelling or difficulty breathing warrants urgent help. Pregnancy concerns or a history of inflammatory bowel disease should be addressed before starting treatment, not after unexpected symptoms occur.
No. Ziana contains clindamycin phosphate 1.2% and tretinoin 0.025%; benzoyl peroxide is not one of its active ingredients.
No. Ziana is a fixed combination containing clindamycin and tretinoin, while a tretinoin-only cream lacks the antibiotic and has its own formulation and labeling.
The U.S. indication is for acne vulgaris in patients 12 years of age and older.
The U.S. label lists regional enteritis, ulcerative colitis and a history of antibiotic-associated colitis under formal contraindications.
The Ziana label says it should not be used together with erythromycin-containing products. Review all current prescriptions with the treating clinician.
The tretinoin-containing formula can increase irritation and sensitivity to UV exposure. Follow the current patient-label sun-protection advice.
The 1.2% clindamycin phosphate content is equivalent to 1% clindamycin base in the gel; it is not a second separate medicine.
Not as a simple generic match. Plain clindamycin lacks tretinoin; the exact prescription and any proposed alternative require professional review.
No. Regulatory labeling confirms product facts, not local stock. Ask the licensed pharmacy about the correct formulation, quantity and current supply.